Showing results (81-90 of 15,737) with videos related to

Sort By:
Pageof 1,574
The Journal of Antimicrobial Chemotherapy|July 7, 2000
The antimicrobial efficacy of a new central venous catheter with long-term broad-spectrum activityJ M Schierholz, C Fleck, J Beuth, et al.
The Journal of Antimicrobial Chemotherapy|July 7, 2000
Antibiotic susceptibility and mechanisms of beta-lactam resistance in 1310 strains of pseudomonas aeruginosa: a French multicentre study (1996)J D Cavallo, R Fabre, F Leblanc, et al.
The Journal of Antimicrobial Chemotherapy|July 6, 2000
A novel approach to antiviral therapy for influenzaP M Colman
The Journal of Antimicrobial Chemotherapy|January 30, 2002
Cefepime is efficacious against penicillin- and quinolone-resistant pneumococci in experimental meningitisPhilippe Cottagnoud, Fernando Acosta, Marianne Cottagnoud, et al.
The Journal of Antimicrobial Chemotherapy|January 30, 2002
Beta-lactam modification of the bacteraemic profile and its relationship with mortality in a pneumococcal mouse sepsis modelJ Yuste, I Jado, A Fenoll, et al.
The Journal of Antimicrobial Chemotherapy|January 30, 2002
Reproducibility of control organism zone diameters for batches of IsoSensitest agar manufactured from 1996 to 2000 using the BSAC disc susceptibility test methodJanine Landrygan, Peter A James, Dawn Brooks, et al.
The Journal of Antimicrobial Chemotherapy|January 30, 2002
Meropenem stability to beta-lactamase hydrolysis and comparative in vitro activity against several beta-lactamase-producing Gram-negative strainsN Franceschini, B Segatore, M Perilli, et al.
The Journal of Antimicrobial Chemotherapy|January 30, 2002
In vitro activity of the aerosolized agents colistin and tobramycin and five intravenous agents against Pseudomonas aeruginosa isolated from cystic fibrosis patients in southwestern GermanyTanja Schülin
The Journal of Antimicrobial Chemotherapy|January 30, 2002
Rifabutin-induced cystoid macular oedemaJ D Vaudaux, Y Guex-Crosier
The Journal of Antimicrobial Chemotherapy|January 30, 2002
Increased in vitro activity of the novel des-fluoro(6) quinolone BMS-284756 against genetically defined clinical isolates of Staphylococcus aureusFranz-Josef Schmitz, Mechthild Boos, Susanne Mayer, et al.
Pageof 1,574